Disclosures for "Describing and Comparing ALS Patients who Request Medical Assistance in Dying with Patients Dying Directly of the Disease"
-
Mr. Trudel has nothing to disclose.
-
Dr. Quesnel-Olivo has nothing to disclose.
-
Mathieu Blais has nothing to disclose.
-
Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.